Monday, February 3, 2014

Map: Current Geographic Distribution of Human A(H7N9) Cases in Eastern China and Taiwan, Nov. 2013 to Feb. 2014



This map shows the geographic distribution of  human H7N9 cases by second level administrative divisions (generally prefecture-level cities) in the People’s Republic of China and Taiwan from the period of November 1, 2013 to February 3, 2014.  The map is based on geolocational information for more than 150 confirmed and reported cases since November 1, 2013.  H7N9 cases from the 2012-2013 flu season are not included on this map.  Geolocational information for individual cases is derived from numerous online reports.

Sunday, February 2, 2014

Status of the Influenza A(H7N9) virus, World Health Organization, January 31, 2014


The World Health Organization (WHO) is an arm of the United Nations and is tasked with monitoring international public health. One of the most important roles of this public health organization is to identify and track novel infectious diseases. MERS-CoV and Influenza A(H7N9) are two recent novel infectious diseases that WHO has been monitoring and tracking recently.

On January 31, 2014, The WHO published a summary of what is known about H7N9 infections, reservoirs, clinical presentation, protection, treatment, and recommendations.
 
WHO report: Background and summary of human infection with avian influenza A(H7N9) virus – as of 31 January 2014

This the first background and summary provided by WHO on H7N9 infections since April 3, 2013 (link). The report summarizes what is known about H7N9 at this time. It is important to understand that WHO provides factual information about the status of H7N9 cases and the disease as it is understood on the day of the report. WHO does not generally provide forecasts or speculate on the pandemic potential for a specific disease such as H7N9.

Here is a brief digest of the WHO report.

H7N9 is infecting individuals over a wide geographic area in eastern China and Taiwan. So far there is no evidence of sustained human to human transmission. WHO does not address the issue of several small family clusters that may represent human-to-human transmission.

The reservoir for the virus has not yet been formally identified but is likely avian in origin. Symptoms of H7N9 are nonspecific, such as fever, cough, and shortness of breath, all of which could be signs of a number of different respiratory infections. Laboratory testing is necessary to confirm H7N9 infection. As with other novel influenza infections, H7N9 seems to respond to treatment with neuraminidase inhibitors. Given early in the infection stage neuraminidase inhibitors can reduce disease severity and possibly increase chances of survival.

Males are infected about twice the rate of females. Although WHO indicates that the case fatality ratio (CFR) is .22 through January 28, 2014, the CFR for infected cases is uncertain because many recent confirmed cases are still hospitalized. Most of the severe reported cases are elderly individuals with chronic conditions. The median age of the cases that have died is 66 years old.

Although H7N9 vaccines are in development, none are currently available in the event of a pandemic outbreak. WHO continues to recommend a variety of prevention and control measures including hand hygiene and use of personal protective equipment (PPE) when in contact with a confirmed patient. As with any acute respiratory infection, droplet protection and the use of PPE including eye protection are recommended. Although aerosolized human-to-human transmission has not been confirmed, proper precautions to avoid aerosolized droplets is also recommended.



In the report WHO provides a number of specific recommendations for public health officials, researchers, clinicians, and laboratory personnel. WHO does not recommend any international screening or travel or trade restrictions  be applied for  H7N9 at this time. 


Discussion

In summary, the lack of an identified host and the wide geographic distributions of cases suggests that H7N9 will not burn itself out soon. The fact that a few mild and asymptomatic cases have been reported provides some hope that a portion of the population has some innate or acquired immunity. H7N9 has now become another emerging infectious disease that has the potential to cause a pandemic. 

Friday, January 24, 2014

More H7N9 cases can be expected in the next several weeks


Based on the reports from the People’s Republic of China (China), there is only limited human to human transmission of the novel A(H7N9) influenza virus.  However the number of sporadic cases reported by China is increasing dramatically.  The distribution of reported cases since November of 2013  has been increasing almost geometrically (graph below). Based on the trendline, between 30-40 cases per week may be expected within the next several weeks in China.


Graph notes: The weekly totals are counts based on reported onset dates for the 2013-2014 influenza season. The data do not include 18 cases announced in the past several days for which onset dates have not yet been reported.

Tuesday, January 21, 2014

Map: H7N9 cases concentrated in northern Zhejiang Province, PRC


Since novel A(H7N9) human infections were first discovered last year in the People's Republic of China, Zhejiang Province has reported the most cases. The map below depicts in aggregate, the general locations of 80 confirmed and unconfirmed cases through January 21, 2014. The cases are concentrated in the northern portion of the country in the Hangzhou and Huzhou. About 70% of all H7N9 cases reported from Zhejiang are from these two prefectures. 



Monday, January 20, 2014

Doctor dies from H7N9 in Shanghai



Chinese translations of media reports by FluTracker’s members indicated that an emergency room doctor has died from an H7N9 infection.(link) If this is confirmed by the World Health Organization it would only be the second confirmed health care worker (HCW) infected with H7N9. The last HCW infected by H7N9 was reported in April 2013.(link) Public health officials are always concerned about reports of health care workersinfected by novel infectious diseases because it is generally a sign of human-to-human transmission.

Saturday, January 18, 2014

CSI 300 Index (China) Trending Down as Number of H7N9 Cases Increases

The chart below is an update to the chart presented on January 14 in Comparison of the CSI 300 Index (China) with the Recent Increase in H7N9 Cases. 

The graph below presents the H7N9 case counts based only on the date of report rather than a combination of onset dates and report dates. This graph more accurately reflects the relationship between the increasing number of reported H7N9 cases and the declining CSI 300 index.

Graph: Comparison of the CSI 300 Index (China) with the recent increase in H7N9 Cases as of January 18, 2014


Friday, January 17, 2014

Map: Geolocations of Human A(H7N9) Cases in Eastern China and Taiwan as of January 17, 2014




The map shows the frequency range of human H7N9 cases by second level administrative divisions (generally prefecture-level cities) in the People’s Republic of China and Taiwan through January 17, 2014. The map is based on geolocational information for more than 190 confirmed and probable cases. Geolocational information for individual cases is derived from numerous online reports and believe to be relatively accurate.